Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Novonix ADR | NVX | Sep 20, 2024 | 1.45 | -0.68 |
NRG Energy | NRG | Sep 20, 2024 | 87.09 | +6.43 |
NRx Pharmaceuticals | NRXP | Sep 20, 2024 | 1.63 | -0.61 |
NSTS Bancorp | NSTS | Sep 20, 2024 | 10.75 | +10.82 |
Nu Holdings | NU | Sep 20, 2024 | 14.63 | -1.15 |
Nu Skin Enterprises | NUS | Sep 20, 2024 | 7.06 | -1.40 |
Nuburu | BURU | Sep 20, 2024 | 0.40 | -4.95 |
NuCana ADR | NCNA | Sep 20, 2024 | 3.21 | -1.38 |
Nucor | NUE | Sep 20, 2024 | 146.31 | -1.81 |
Nukkleus | NUKK | Sep 20, 2024 | 0.21 | +3.06 |
Nurix Therapeutics | NRIX | Sep 20, 2024 | 25.62 | +2.23 |
NuScale Power | SMR | Sep 20, 2024 | 10.70 | +11.34 |
Nustar Energy C Pref | NS-C | Sep 20, 2024 | 24.99 | 0.00 |
Nutanix A | NTNX | Sep 20, 2024 | 60.82 | +3.10 |
Nutex Health | NUTX | Sep 20, 2024 | 24.50 | -2.66 |
Nutriband | NTRB | Sep 20, 2024 | 6.17 | +10.18 |
Nutrien | NTR | Sep 20, 2024 | 47.06 | -1.75 |
Nuvalent A | NUVL | Sep 20, 2024 | 108.00 | +4.60 |
Nuvation Bio A | NUVB | Sep 20, 2024 | 2.80 | -5.08 |
Nuvectis Pharma | NVCT | Sep 20, 2024 | 6.50 | -3.70 |
Nuveen Amtfree Municipal Credit Income Fund | NVG | Sep 20, 2024 | 13.31 | +0.08 |
Nuveen Amtfree Municipal Value Fund | NUW | Sep 20, 2024 | 14.26 | -0.14 |
Nuveen Amtfree Quality Municipal Income Fund | NEA | Sep 20, 2024 | 11.85 | -0.08 |
Nuveen Arizona Quality Municipal Fund | NAZ | Sep 20, 2024 | 11.72 | 0.00 |
Nuveen California Amtfree Quality Municipal Income Fund | NKX | Sep 20, 2024 | 13.85 | -0.22 |
Nuveen California Municipal Value Fund | NCA | Sep 20, 2024 | 9.10 | -0.22 |
Nuveen California Quality Municipal Income Fund | NAC | Sep 20, 2024 | 11.92 | -0.42 |
Nuveen California Select Taxfree Income Portfolio | NXC | Sep 20, 2024 | 14.00 | -0.50 |
Nuveen Churchill Direct Lending | NCDL | Sep 20, 2024 | 17.66 | -1.29 |
Nuveen Core Equity Alpha Fund | JCE | Sep 20, 2024 | 15.07 | -0.46 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.